Inhibition of cerebral type 1 cannabinoid receptors is associated with impaired auditory mismatch negativity generation in the ketamine model of schizophrenia - Roser, P; Haussleiter, I S; Chong, H J (Psychopharmacology (Berl), 2011)
et al.